BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35484177)

  • 21. Increased LACTB2 Expression Regulates Oxidative Phosphorylation and mTORC1 Signaling of Colorectal Cancer.
    Li H; Wen JY; Liu CZ; Fang YY; Ye YP; Zeng DT; Pan YF; Chen ZX; Liu LM; Song R
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38664305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
    Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
    Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics prognostic signatures of IPO11 mRNA expression and clinical outcomes in colorectal cancer using bioinformatics approaches.
    Aljahdali MO; Molla MHR
    Health Inf Sci Syst; 2023 Dec; 11(1):57. PubMed ID: 38028961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer.
    Kuthethur R; Jerome MS; Subbannayya Y; Chakrabarty S
    Breast Cancer; 2023 Sep; 30(5):832-844. PubMed ID: 37344703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
    Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
    Front Genet; 2022; 13():1054152. PubMed ID: 36506313
    [No Abstract]   [Full Text] [Related]  

  • 27. Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.
    Manils J; Marruecos L; Soler C
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.
    Song D; Zhang D; Chen S; Wu J; Hao Q; Zhao L; Ren H; Du N
    Sci Rep; 2022 Apr; 12(1):6946. PubMed ID: 35484177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Song D; Zhou Z; Zhang D; Wu J; Hao Q; Zhao L; Ren H; Zhang B
    Front Genet; 2022; 13():850200. PubMed ID: 35711939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data.
    Remák E; Hawkins N; Jones T; Otley M; Twigger R; Prince M
    Eur J Cancer; 2021 Oct; 156 Suppl 1():S18. PubMed ID: 34649645
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.